Stock NGVT INGEVITY CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Financials Ingevity Corporation

Equities

NGVT

US45688C1071

Diversified Chemicals

Market Closed - Nyse
Other stock markets
 04:00:02 2024-04-26 pm EDT 		5-day change 1st Jan Change
48.51 USD +1.34% Intraday chart for Ingevity Corporation +9.16% +2.73%
Apr. 22 Ingevity Shares Rise After Jefferies Upgrades Stock to Buy From Hold, Raises Price Target MT
Apr. 22 Jefferies Upgrades Ingevity to Buy From Hold, Raises Price Target to $62 From $52 MT

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 3,655 3,126 2,817 2,632 1,711 1,760 - -
Enterprise Value (EV) 1 4,827 4,136 3,791 4,028 3,082 3,018 2,779 2,661
P/E ratio 20.1 x 16.9 x 24.3 x 12.8 x -315 x 13.2 x 9.79 x -
Yield - - - - - - - -
Capitalization / Revenue 2.83 x 2.57 x 2.02 x 1.58 x 1.01 x 1.21 x 1.14 x 1.11 x
EV / Revenue 3.73 x 3.4 x 2.72 x 2.41 x 1.82 x 2.07 x 1.8 x 1.67 x
EV / EBITDA 12.2 x 10.4 x 8.98 x 8.9 x 7.77 x 7.94 x 6.23 x 5.67 x
EV / FCF 30 x 15.3 x 20 x 23.6 x 32.3 x 32.5 x 15 x 13.7 x
FCF Yield 3.33% 6.54% 4.99% 4.24% 3.09% 3.08% 6.66% 7.29%
Price to Book 6.89 x 4.9 x 4.18 x 3.76 x - - - -
Nbr of stocks (in thousands) 41,824 41,279 39,286 37,372 36,231 36,281 - -
Reference price 2 87.38 75.73 71.70 70.44 47.22 48.51 48.51 48.51
Announcement Date 2/3/20 2/10/21 2/23/22 2/27/23 2/21/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 1,293 1,216 1,392 1,668 1,692 1,456 1,544 1,590
EBITDA 1 396.9 397.9 422.2 452.6 396.8 380.2 446.3 469.5
EBIT 1 311.9 297.7 312.3 343.8 76.9 255.5 327.3 346
Operating Margin 24.12% 24.48% 22.44% 20.61% 4.54% 17.55% 21.19% 21.75%
Earnings before Tax (EBT) 1 227.9 235.1 162.8 269.6 -10.1 172.4 239 -
Net income 1 183.7 186.2 118.1 211.6 -5.4 133.4 184.9 -
Net margin 14.21% 15.31% 8.49% 12.68% -0.32% 9.16% 11.97% -
EPS 2 4.350 4.480 2.950 5.500 -0.1500 3.675 4.957 -
Free Cash Flow 1 160.9 270.3 189.2 170.6 95.3 93 185.2 194
FCF margin 12.44% 22.23% 13.6% 10.23% 5.63% 6.39% 11.99% 12.2%
FCF Conversion (EBITDA) 40.54% 67.93% 44.81% 37.69% 24.02% 24.46% 41.49% 41.32%
FCF Conversion (Net income) 87.59% 145.17% 160.2% 80.62% - 69.72% 100.16% -
Dividend per Share - - - - - - - -
Announcement Date 2/3/20 2/10/21 2/23/22 2/27/23 2/21/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales 1 376.8 336 382.8 419.9 482 383.6 392.6 481.8 446 371.7 319.2 419.9 398.8 323 332.9
EBITDA 1 119.5 79.6 119 121.1 138.2 74.3 103.9 120.7 110.4 61.8 63.46 107.1 115.6 92.68 89.83
EBIT 1 91.9 51.4 88.3 91.6 107.3 44.1 72.8 69.3 55.2 -131.3 32.67 75.3 86.97 60.53 79.1
Operating Margin 24.39% 15.3% 23.07% 21.81% 22.26% 11.5% 18.54% 14.38% 12.38% -35.32% 10.24% 17.93% 21.81% 18.74% 23.76%
Earnings before Tax (EBT) 1 -9 36.3 77.6 76.5 95.8 19.7 64.1 47.7 32.1 -154 7.4 49.9 60.5 33.75 39.4
Net income 1 -4.2 29.3 60.8 59.8 75.4 15.6 50.7 35.5 25.2 -116.8 5.7 19.95 46.55 26 30.35
Net margin -1.11% 8.72% 15.88% 14.24% 15.64% 4.07% 12.91% 7.37% 5.65% -31.42% 1.79% 4.75% 11.67% 8.05% 9.12%
EPS 2 -0.1100 0.7400 1.550 1.540 1.980 0.4100 1.350 0.9700 0.6900 -3.230 0.2000 1.030 1.223 0.8300 0.8350
Dividend per Share - - - - - - - - - - - - - - -
Announcement Date 10/27/21 2/23/22 5/4/22 8/2/22 11/2/22 2/27/23 5/3/23 8/2/23 11/1/23 2/21/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 1,172 1,010 975 1,396 1,371 1,258 1,019 901
Net Cash position 1 - - - - - - - -
Leverage (Debt/EBITDA) 2.953 x 2.538 x 2.308 x 3.084 x 3.456 x 3.309 x 2.283 x 1.919 x
Free Cash Flow 1 161 270 189 171 95.3 93 185 194
ROE (net income / shareholders' equity) - - - - - - - -
ROA (Net income/ Total Assets) - - - - - - - -
Assets 1 - - - - - - - -
Book Value Per Share 12.70 15.50 17.20 18.70 - - - -
Cash Flow per Share 6.530 8.480 7.310 - - - - -
Capex 1 115 82.1 104 143 110 117 115 117
Capex / Sales 8.88% 6.75% 7.46% 8.54% 6.49% 8.01% 7.47% 7.36%
Announcement Date 2/3/20 2/10/21 2/23/22 2/27/23 2/21/24 - - -
1USD in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Ratings for Ingevity Corporation

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
7
Last Close Price
48.51 USD
Average target price
57.86 USD
Spread / Average Target
+19.27%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Diversified Chemicals

1st Jan change Capi.
INGEVITY CORPORATION Stock Ingevity Corporation
+2.73% 1.76B
SHIN-ETSU CHEMICAL CO., LTD. Stock Shin-Etsu Chemical Co., Ltd.
-0.19% 74.89B
BASF SE Stock BASF SE
+0.09% 46.52B
DUPONT DE NEMOURS, INC. Stock DuPont de Nemours, Inc.
-4.19% 30.82B
PIDILITE INDUSTRIES LIMITED Stock Pidilite Industries Limited
+9.85% 18.19B
BRENNTAG SE Stock Brenntag SE
-10.05% 11.54B
EASTMAN CHEMICAL COMPANY Stock Eastman Chemical Company
+6.39% 11.24B
SYENSQO SA/NV Stock Syensqo SA/NV
-8.09% 9.73B
ASAHI KASEI CORPORATION Stock Asahi Kasei Corporation
+2.79% 9.4B
SRF LIMITED Stock SRF Limited
+6.35% 9.37B
Diversified Chemicals
  1. Stock Market
  2. Equities
  3. NGVT Stock
  4. Financials Ingevity Corporation